From Genes to Novel Therapeutics in Autism – J. Buxbaum, Icahn School of Medicine @Synchrony2020
Synchrony 2020 HIGHLIGHTS: 'From Genes to Novel Therapeutics in Autism' - Joseph Buxbaum PhDПодробнее
From gene discovery to novel therapeutics in autism spectrum disorderПодробнее
Gene Discovery as a Basis for Precision Medicine in Autism | 2024 Advances in Autism ConferenceПодробнее
Developing Novel Therapeutics in Autism Spectrum Disorder: Trials and TribulationsПодробнее
Joseph Buxbaum, From Gene Discovery to Novel Therapeutics: Poitras Center and Stanley CenterПодробнее
From Rare Mutations to Common Treatments in Autism - M. Lalli PhD, Icahn School of Med. @Synchrony22Подробнее
FBI Cyber Series - Gene discovery and precision medication in autism spectrum disorderПодробнее
Genetics of Autism Spectrum Disorders: From Genes to Novel TherapeuticsПодробнее
Connecting Rare Genetic Mutations in ASD to Common Biological Pathways- J Buxbaum PhD @Synchrony2021Подробнее
Genetics and Neurodevelopmental Disorders | 2019 Advances in Autism ConferenceПодробнее
Understanding & Treating Autism: Neuroarcheology Concept - Y Ben Ari PhD, Neurochlore @Synchrony2020Подробнее
Therapeutics To Improve Outcomes In Autism As Informed By Genetics - Richard Boles MD @Synchrony2020Подробнее
The Benefits of Genetic Testing In AutismПодробнее
Longitudinal Study of GI Treatment in Autism ASD - Arthur Krigsman, MD @Synchrony2020Подробнее
New ASD Therapeutic Agents in Development - Gahan Pandina PhD, Jannsen R&D @Synchrony2020Подробнее
Signs of Undiagnosed Autism in AdultsПодробнее
Autism researcher Joseph Buxbaum describes the SHANK3 gene and the promise of IGF1Подробнее
Potential for prevention of developmental disorders including autism -E Quadros, SUNY @Synchrony2020Подробнее
